The Wall Street Journal reports that the Centers for Medicare and Medicaid Services, the government agency responsible for regulating clinical laboratories, concluded its inspection on September 29, just a few days before Theranos decided to shut down all of its clinical labs on October 5. The deficiencies found as a result of that inspection have resulted in more blood tests getting voided in addition to the two years' worth of blood tests it had previously voided.
Inspectors found deficiencies at Theranos' Arizona lab just days before the company closed all of its labs
Before it closed its Arizona lab, Theranos failed an inspection that the company hadn't disclosed.
In October, Theranos pivoted to focus solely on developing its technology instead of simultaneously operating clinical laboratories. The end goal? GettingThe technology debuted in August as part of Theranos' attempt to be what Holmes called a "decentralized" lab, meaning the test could be processed without needing to be shipped back to a brick-and-mortar lab.
On Tuesday, the company announced a new technology advisory board that would
Theranos' saga came into the spotlight in October 2015 after The Wall Street Journal published an investigation that questioned the accuracy of Theranos' blood test. In 2016, Theranos' northern California location was shut down, and Holmes was barred for two years from running a clinical lab, which Theranos has since appealed.
Eyewitness? Submit your stories now via social or:
Email: news@pulselive.co.ke